Cargando…
Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population
Metabolic syndrome (MetS) is a worldwide problem with severe health consequences. In this study, we examine the changes in the prevalence of MetS and its components in two disadvantaged counties of Northeastern Hungary. Two health examination surveys were performed in the Hungarian population aged 2...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829989/ https://www.ncbi.nlm.nih.gov/pubmed/33467044 http://dx.doi.org/10.3390/jpm11010052 |
_version_ | 1783641301148762112 |
---|---|
author | Piko, Peter Dioszegi, Judit Sandor, Janos Adany, Roza |
author_facet | Piko, Peter Dioszegi, Judit Sandor, Janos Adany, Roza |
author_sort | Piko, Peter |
collection | PubMed |
description | Metabolic syndrome (MetS) is a worldwide problem with severe health consequences. In this study, we examine the changes in the prevalence of MetS and its components in two disadvantaged counties of Northeastern Hungary. Two health examination surveys were performed in the Hungarian population aged 20–64 years in 2006 (n = 450) and 2018 (n = 397) and the data were compared to each other. It was found that the prevalence of MetS increased significantly in the period examined (from 34.9% to 42.2%, p = 0.035) due to the increased prevalence of raised blood pressure (from 45.6% to 57.0%, p = 0.002) and raised fasting glucose concentration (13.2% vs. 24.8%, p < 0.001). The increase mainly affects the younger (20–34 years old) age group (12.1% in 2006 vs. 31.6% in 2018, p = 0.001). It is quite alarming that the prevalence of MetS and its components has increased significantly in the last decade, while the prevalence of preventive medication is unchanged (antihypertensive and antidiabetic treatments) or even significantly decreased (lipid-lowering medication). Consequently, the number of individuals untreated for hypertension and metabolic disturbances is severely increased. A targeted public health strategy is desperately needed to prevent further worsening the situation. |
format | Online Article Text |
id | pubmed-7829989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78299892021-01-26 Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population Piko, Peter Dioszegi, Judit Sandor, Janos Adany, Roza J Pers Med Article Metabolic syndrome (MetS) is a worldwide problem with severe health consequences. In this study, we examine the changes in the prevalence of MetS and its components in two disadvantaged counties of Northeastern Hungary. Two health examination surveys were performed in the Hungarian population aged 20–64 years in 2006 (n = 450) and 2018 (n = 397) and the data were compared to each other. It was found that the prevalence of MetS increased significantly in the period examined (from 34.9% to 42.2%, p = 0.035) due to the increased prevalence of raised blood pressure (from 45.6% to 57.0%, p = 0.002) and raised fasting glucose concentration (13.2% vs. 24.8%, p < 0.001). The increase mainly affects the younger (20–34 years old) age group (12.1% in 2006 vs. 31.6% in 2018, p = 0.001). It is quite alarming that the prevalence of MetS and its components has increased significantly in the last decade, while the prevalence of preventive medication is unchanged (antihypertensive and antidiabetic treatments) or even significantly decreased (lipid-lowering medication). Consequently, the number of individuals untreated for hypertension and metabolic disturbances is severely increased. A targeted public health strategy is desperately needed to prevent further worsening the situation. MDPI 2021-01-16 /pmc/articles/PMC7829989/ /pubmed/33467044 http://dx.doi.org/10.3390/jpm11010052 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Piko, Peter Dioszegi, Judit Sandor, Janos Adany, Roza Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title | Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title_full | Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title_fullStr | Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title_full_unstemmed | Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title_short | Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population |
title_sort | changes in the prevalence of metabolic syndrome and its components as well as in relevant preventive medication between 2006 and 2018 in the northeast hungarian population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829989/ https://www.ncbi.nlm.nih.gov/pubmed/33467044 http://dx.doi.org/10.3390/jpm11010052 |
work_keys_str_mv | AT pikopeter changesintheprevalenceofmetabolicsyndromeanditscomponentsaswellasinrelevantpreventivemedicationbetween2006and2018inthenortheasthungarianpopulation AT dioszegijudit changesintheprevalenceofmetabolicsyndromeanditscomponentsaswellasinrelevantpreventivemedicationbetween2006and2018inthenortheasthungarianpopulation AT sandorjanos changesintheprevalenceofmetabolicsyndromeanditscomponentsaswellasinrelevantpreventivemedicationbetween2006and2018inthenortheasthungarianpopulation AT adanyroza changesintheprevalenceofmetabolicsyndromeanditscomponentsaswellasinrelevantpreventivemedicationbetween2006and2018inthenortheasthungarianpopulation |